首页> 外文期刊>Frontiers in Neuropharmacology >Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation”
【24h】

Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation”

机译:社论:“新型疼痛治疗方法:从基础研究到临床翻译和康复”

获取原文
       

摘要

Chronic pain is a major public health problem representing a global leading cause of disability and disease burden with low back pain and headache disorders ranking top-ten as causes of disabilityadjusted life-years (DALYs) throughout the whole lifetime from teenage to old age (Diseases and Injuries, 2020). In fact, some 30–50% of the world population and almost 20% of the Europeans actually suffer from chronic pain with devastating cost for the society in terms of disability and hospitalization (Breivik et al., 2006; Reid et al., 2011; van Hecke et al., 2013; Mills et al., 2019).
机译:慢性疼痛是一个主要的公共卫生问题,代表残疾和疾病负担的全球性良好原因,低腰疼痛和头痛障碍排名前十名作为残疾人寿命的生命年龄(Dalys)的原因,从青少年到老年(疾病) 和伤害,2020)。 事实上,世界人口的约30-50%,近20%的欧洲人实际上患有慢性痛苦,在残疾和住院方面具有毁灭性的社会成本(Breivik等,2006; Reid等,2011 ; van Hecke等,2013; Mills等,2019)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号